Penile Reconstruction
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Part 2-Organ-Sparing Procedures in Testicular and Penile Tumors
International Urology and Nephrology (2019) 51:1699–1708 https://doi.org/10.1007/s11255-019-02182-6 UROLOGY - REVIEW Organ‑sparing procedures in GU cancer: part 2‑organ‑sparing procedures in testicular and penile tumors Mohamed H. Kamel1,3 · Mahmoud I. Khalil1,3 · Ehab Eltahawy1,3 · Rodney Davis1 · Nabil K. Bissada2 Received: 1 May 2019 / Accepted: 23 May 2019 / Published online: 2 July 2019 © Springer Nature B.V. 2019 Abstract Purpose Organ-sparing surgery (OSS) is recommended in selected patients with testicular tumors and penile cancer (PC). The functional and psychological impacts of organ excision for these genital tumors are profound. In this review, we sum- marize the indications, techniques and outcomes of OSS for these two tumors. Methods PubMed® was searched for relevant articles up to December 2018. For Testicular sparing surgery (TSS) search, keywords used were; testicular tumors alone and in combination with “testicular sparing surgery”, “partial orchiectomy” and outcomes. For penile conserving surgery (PCS), keywords used were: penile cancer alone and in combination with “penile conserving surgery”, “partial penectomy” and outcomes. Because of the low quality of available evidence, a narrative rather that systematic review has been performed. Results Indications of TSS are tumors ≤ 2 cm in solitary testis or bilateral tumors and no rete testis invasion. Prerequisites include normal testosterone and luteinizing hormone levels and patient compliance with follow-up. Indications for PCS are distal penile lesions with clinical stage ≤ T1. Adequate penile stump (3 cm) is required after surgery to maintain forward urine stream. Frozen section helps to reduce the risk of recurrence. Local recurrence after PCS is not associated with reduced survival and can be managed with another PCS in selected patients. -
EAU Guidelines on Penile Cancer 2001
European Association of Urology GUIDELINES ON PENILE CANCER* F. Algaba, S. Horenblas, G. Pizzocaro, E. Solsona, T. Windahl TABLE OF CONTENTS PAGE 1. Background 3 2. Classification 3 2.1 Pathology 3 2.2 References 4 3. Risk factors 5 3.1 References 5 4. Diagnosis 6 4.1 Primary lesion 6 4.2 Regional nodes 6 4.3 Distant metastases 7 4.4 Guidelines on the diagnosis of penile cancer 8 4.5 References 8 5. Treatment 9 5.1 Primary lesion 9 5.2 Regional nodes 9 5.3 Guidelines on the treatment of penile carcinoma 11 5.4 Integrated therapy 11 5.5 Distant metastases 11 5.6 Quality life 11 5.7 Technical aspects 12 5.8 Chemotherapy 12 5.9 References 14 6. Follow-up 15 6.1 Why follow-up? 15 6.2 How to follow-up 16 6.3 When to follow-up 16 6.4 Guidelines for follow-up in penile cancer 17 6.5 References 18 7. Abbreviations used in the text 19 2 1. BACKGROUND Penile carcinoma is an uncommon malignant disease with an incidence ranging from 0.1 to 7.9 per 100,000 males. In Europe, the incidence is 0.1–0.9 and in the US, 0.7–0.9 per 100,000 (1). In some areas, such as Asia, Africa and South America, penile carcinoma accounts for as many as 10–20% of male cancers. Phimosis and chronic irritation processes related to poor hygiene are commonly associated with this tumour, whereas neonatal circumcision gives protection against the disease. -
Gender Affirming Surgery and Related Procedures State(S): LOB(S): Idaho Montana Oregon Washington Other: Commercial Medicare Medicaid
Gender Affirming Surgery and Related Procedures State(s): LOB(s): Idaho Montana Oregon Washington Other: Commercial Medicare Medicaid Enterprise Policy BACKGROUND The American Psychiatric Association’s Diagnostic and Statistical Manual, 5th Edition (DSM 5) defines criterion A of Gender Dysphoria as “a marked incongruence between one’s experience/expressed gender and assigned gender.” These individuals must meet additional criteria which include persistence over time and clinically significant distress or impairment in social, occupational or other important areas of functioning. Benefits must be verified by reviewing the plan’s contract or plan document (PD). Some PacificSource benefit plans do not include coverage of gender affirming surgery, procedures or other related treatment. Groups may elect to customize these benefits; therefore, benefit determinations are based on specific contract language. CRITERIA The member should be placed into case management by Health Services as a way to help the member understand their benefits and required criteria related to gender affirming surgery and treatment, and to assist her/him to navigate the system and promote an optimal outcome. Covered Services and Exclusions – Commercial, Medicaid 1. The following are considered medically necessary gender affirming surgeries. a. Core surgical procedures considered medically necessary for females transitioning to males include: hysterectomy, vaginectomy, salpingo-oophorectomy, metoidioplasty, phalloplasty, urethroplasty, scrotoplasty, perineal electrolysis, and placement of testicular implant and mastectomy including nipple reconstruction. b. Core surgical procedures considered medically necessary for males transitioning to females include: penectomy, orchiectomy, vaginoplasty, clitoroplasty, perineal electrolysis, labiaplasty, and mammoplasty when 12 continuous months of hormonal (estrogen) therapy has failed to result in breast tissue growth of Tanner Stage 5 on the puberty scale or there is any contraindication to, or intolerance of, or patient refusal of hormone therapy. -
Delineation of Privileges Urology Privileges Provider Name
Delineation Of Privileges Urology Privileges Provider Name: Privilege Requested Deferred Approved UROLOGY PRIVILEGES Criteria - New Applicants:: Board Certification or qualified for certification by the American Board of Urology. Criteria - Current Staff Members Only: Successful completion of an ACGME or AOA approved training program; OR demonstrated acceptable practice in the privileges being requested for a minimum of five (5) years. Proctoring Requirements: A minimum of eight (8) cases, in accordance with the Medical Staff Proctoring Protocol. GENERAL PRIVILEGES: Admit ___ ___ ___ Consultation Only Privileges ___ ___ ___ Surgical Assist Only ___ ___ ___ Local block anesthesia ___ ___ ___ Regional block anesthesia ___ ___ ___ Sedation analgesia ___ ___ ___ Criteria: Requires successful completion of the Sedation Assessment test. Additional criteria effective April 1, 2015: a) Evidence of current ACLS and/or PALS certification from the American Heart Association; AND b) Evidence of completion of an Airway Management Course a) Adult Sedation ___ ___ ___ b) Pediatric Sedation (17 years and under) ___ ___ ___ CATEGORY 1 - UROLOGY PRIVILEGES ___ ___ ___ Includes the management and coordination of care, treatment and services, including: medical history and physical evaluations, consultations and prescribing medication in accordance with DEA certificate. Urethral, bladder catheterization ___ ___ ___ Suprapubic, bladder aspiration ___ ___ ___ Page 1 Printed on Wednesday, December 10, 2014 Delineation Of Privileges Urology Privileges Provider -
A Comprehensive Review of a Rare Subclass of Mucosal Melanoma with Emphasis on Differential Diagnosis and Therapeutic Approaches
cancers Review Urological Melanoma: A Comprehensive Review of a Rare Subclass of Mucosal Melanoma with Emphasis on Differential Diagnosis and Therapeutic Approaches Gerardo Cazzato 1,*,† , Anna Colagrande 1,†, Antonietta Cimmino 1, Concetta Caporusso 1, Pragnell Mary Victoria Candance 1, Senia Maria Rosaria Trabucco 1, Marcello Zingarelli 2, Alfonso Lorusso 2, Maricla Marrone 3 , Alessandra Stellacci 3 , Francesca Arezzo 4, Andrea Marzullo 1, Gabriella Serio 1, Angela Filoni 5, Domenico Bonamonte 5, Paolo Romita 5, Caterina Foti 5, Teresa Lettini 1 , Vera Loizzi 4, Gennaro Cormio 4 , Leonardo Resta 1 , Roberta Rossi 1,‡ and Giuseppe Ingravallo 1,‡ 1 Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari “Aldo Moro”, 70124 Bari, Italy; [email protected] (A.C.); [email protected] (A.C.); [email protected] (C.C.); [email protected] (P.M.V.C.); [email protected] (S.M.R.T.); [email protected] (A.M.); [email protected] (G.S.); [email protected] (T.L.); [email protected] (L.R.); [email protected] (R.R.); [email protected] (G.I.) 2 Section of Urology, Deparment of Emergency and Organ Transplantation (DETO), University of Bari “Aldo Moro”, 70124 Bari, Italy; [email protected] (M.Z.); [email protected] (A.L.) 3 Section of Legal Medicine, Interdisciplinary Department of Medicine, Bari Policlinico Hospital, Citation: Cazzato, G.; Colagrande, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124 Bari, Italy; [email protected] (M.M.); A.; Cimmino, A.; Caporusso, C.; [email protected] (A.S.) Candance, P.M.V.; Trabucco, S.M.R.; 4 Section of Ginecology and Obstetrics, Department of Biomedical Sciences and Human Oncology, Zingarelli, M.; Lorusso, A.; Marrone, University of Bari Aldo Moro, Piazza Giulio Cesare 11, 70124 Bari, Italy; [email protected] (F.A.); M.; Stellacci, A.; et al. -
Jared J. Wallen MD MBA
Jared J. Wallen MD MBA Education Post American Board of Urology – Board Certification (Expires 02/28/2029) Massachusetts Institute of Technology – Certificate Commercial Real Estate Analysis and Investing (Class of 2019) London School of Economics and Political Science – Certificate Masters of Business Administration Essentials (Class of 2019) Masters in Real Estate Fortune Builders (Class of 2020) Florida Real Estate Sales Associate License Certification (09/2020) Designation as National Commercial Real Estate Advisor and Certified Real Estate Investment Planning Specialist (01/2021) Fell. Boston Scientific Men’s Sexual Health Research Fellow, Class of 2018 P.G. University of Southern Florida – Morsani College of Medicine, Urologic Surgery Residency, Class of 2017 University of Southern Florida – Morsani College of Medicine, General Surgery Internship, Class of 2013 M.D. Rush Medical College, Doctorate in Medicine, Class of 2012 B.S. University of Illinois Urbana/Champaign, Bachelors with Honors in Molecular and Cellular Biology and Psychology, Class of 2008 A.A. Rock Valley Community College, Associates in Arts, Concentration in Psychology, Class of 2004 Experience • Manager and Lead Urologic Surgeon – YOU & WEE Urologic 10/2020 – present Surgery and Wellness • Manager – RUFF & RESTORE EcoFriendly Properties 11/2019 – present • Founder Men’s Health Survivorship Foundation 10/2018 - present • Board Certified Urologic Surgeon – Advent Health Tampa 10/2017 - 10/2020 Physician Group Urology • Adjunct Faculty - Lincoln Memorial University DCOM 02/2018 – 10/2020 • Consultant Boston Scientific 05/2019 – present 05/2019 - present • Consultant Myriad Genetics • Aquatics Student Coordinator Campus Recreation at University 06/2006 - 06/2008 of Illinois • Assistant Store Manager Valvoline Instant Oil Change 06/2001 - 08/2004 Jared J. -
Counter Incision Is a Safe and Effective Method for Alternative Reservoir Placement During Inflatable Penile Prosthesis Surgery
2696 Original Article Counter incision is a safe and effective method for alternative reservoir placement during inflatable penile prosthesis surgery Dominic Grimberg1^, Sabrina Wang2, Evan Carlos1, Brent Nosé1, Shelby Harper2, Aaron C. Lentz1 1Division of Urology, Duke University Medical Center, Durham, NC, USA; 2Duke University School of Medicine, Durham NC, USA Contributions: (I) Conception and Design: D Grimberg, E Carlos, AC Lentz; (II) Administrative support: D Grimberg, B Nosé, S Wang, S Harper; (III) Provision of study materials or patients: AC Lentz; (IV) Collection and assembly of data: D Grimberg, B Nosé, S Wang, S Harper, E Carlos; (V) Data analysis and interpretation: D Grimberg, E Carlos, B Nosé, AC Lentz; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Dr. Dominic Grimberg. Division of Urology, Duke University Medical Center, Room 1573, White Zone, Durham, NC, 27710, USA. Email: [email protected]. Background: Alternative reservoir placement is increasingly popular during inflatable penile prosthesis (IPP) surgery to prevent intraperitoneal positioning, bowel, bladder, or vascular injury in patients with prior pelvic surgeries. Counter incision (CI) can be used for submuscular reservoir placement in high risk patients, however series exploring the safety remain limited. Methods: A database of IPP surgeries was queried for use of a CI during reservoir placement to compare 90-day clinical outcomes in a retrospective case-control study. Primary outcome was device infections, with secondary outcomes including reservoir herniation, hematoma, device malfunction rates, and operative times. Groups were compared using Kruskal-Wallis and Chi-Squared tests, with multivariate logistic regression models to identify predictors of infectious complications. -
Provider Guide
Physician-Related Services/ Health Care Professional Services Provider Guide July 1, 2015 Physician-Related Services/Health Care Professional Services About this guide* This publication takes effect July 1, 2015, and supersedes earlier guides to this program. Washington Apple Health means the public health insurance programs for eligible Washington residents. Washington Apple Health is the name used in Washington State for Medicaid, the children's health insurance program (CHIP), and state- only funded health care programs. Washington Apple Health is administered by the Washington State Health Care Authority. What has changed? Subject Change Reason for Change Medical Policy Updates Added updates from the Health Technology Clinical In accordance with WAC Committee (HTCC) 182-501-0055, the agency reviews the recommendations of HTCC and decides whether to adopt the recommendations Bariatric surgeries Removed list of agency-approved COEs and added Clarification link to web page for approved COEs Update to EPA Removed CPT 80102 CPT Code Update 870000050 Added CPT 80302 Maternity and delivery – Added intro paragraph for clarification of when to Clarification Billing with modifiers bill using modifier GB. Also updated column headers for modifiers Immune globulins Replacing deleted codes Q4087, Q4088, Q4091, and Updating deleted codes Q4092 with J1568, J1569, J1572, and J1561 Bilateral cochlear implant EPA 870001365 fixed diagnosis code 398.18 Corrected typo Newborn care The agency pays a collection fee for a newborn Clarification metabolic screening panel. The screening kit is provided free from DOH. Vaccines/Toxoids Add language “Routine vaccines are administered Clarification (Immunizations) according to current Centers for Disease Control (CDC) advisory committee on immunization practices (ACIP) immunization schedule for adults and children in the United States.” Injectable and nasal flu Adding link to Injectable Fee Schedule for coverage Clarification vaccines details * This publication is a billing instruction. -
Penile Prosthesis Implantation Fried Symposium 2016
Penile Prosthesis Implantation Fried Symposium 2016 Culley C. Carson III, MD, FACS, FRCS(hon) University of North Carolina Chapel Hill, N.C. Management of ED All Patients Sexual/ Physical Exam Laboratory Tests Medical History Discuss Options Noninvasive Tx Additional Tests (Oral, VED, MUSE, PEP) (NPT, Doppler, DICC) Surgical/Invasive Tx ** Penile Prosthesis History • Bogaras(1936)-Rib • Pearman(1967)- cartilage Trimable silicone • Frumkin(1943)-Rib implant cartilage • Morales(1973)- • Scardino (1950)- Intracavernosal Acrylic stent implant • Goodwin & • Small & Scott(1952)-Acrylic Carrion(1973)- stent Intracavernosal • Lash(1964)-Silicone implant implant • Scott(1973)-Inflatable implant Types of Prostheses • Malleable/semirigid – AMS, Coloplast, Jonas • Mechanical rod – AMS Dura II • Inflatable – 2-piece – AMS Ambicor – 3-piece – • AMS 700 (CX, CXR, LGX) • Coloplast (Alpha-1, Titan, Narrow Base) Penile Prosthesis Modifications • Single tubing connectors • Lock-out valve in fluid reservoir or pump to prevent autoinflation • Parylene Coating • Pump Improvements – MS (AMS) – OTR (Coloplast) • Prevention of infections – Antibiotic-impregnated coating (InhibiZone™, AMS) – Hydrophilic/anti-adherence surface (Titan, Mentor) Penile Implant Indications • Oral drug (PDE5 inhibitor) failure • Radical Prostatectomy • Diabetes mellitus • Cardiovascular • Scarred penis – Priapism – Previous implant – Trauma • Peyronie’s disease • Severe venous leak Issues Regarding Informed Consent • Size of penis—usually slight loss in penile length • Possible need -
Selected Non-Moderated Posters
International Journal of Impotence Research (2001) 13, Suppl 2, S17±S21 ß 2001 Nature Publishing Group All rights reserved 0955-9930/01 $15.00 www.nature.com/ijir Selected Non-moderated Posters 12 \' ASECOMY llEHA \'!ORAL EFFECTS IN MEN Authors: T. Bandel; R. Bauer; T. Sigerson. Bayer AG., Wuppertal, Germany Aragao, A J, Rodrigues A 0., Agostinho AG., Juliano, RV. \1arinc!li CM., Affiliation: Pharmacology, Bayer AG, Wuppertal, Germany Wroclavski, ER., Bozzo, I.S Objective: Evaluate the satisfaction degree and the behavioral effecb or vasectomy in the couple and in the man in matter VARDENAFIL'S IMPROVEMENT ON THE QUALITY OF ERECTIONS CAN BE Method There were selected 113 men submit1ed to sterilization by vasectomy, in DEMONSTRATED EARLY IN RIGfSCAN™ STUDIES. the period from January of 1996 to January of 1999, after approval of the Ethics ·commission of Family Planning Service from the Faculdadc de Medicina do ABC. A.JI the patients were called b~· Introduction and Objectives letter. telegram or phone calls, in a spontaneous way and not obligatory A di red questionnaire Vardenafil is a new highly selective PDE5 inhibitor that is being developed for treatment of \Vas used approaching the following: self-esteem aspects, orgasm corHroL sexual satisfaction, erectile dysfunction. ln two Phase Ila studies with patients with mild to moderate erectile complications, sexual habit and masturbation dysfunction, Rigiscan™ measurements of quality of erections were determined. The objective Results: 23,5% of the patients told that, the sexual relationship performance got of this retrospective analysis was to compare the effect ofvardcnafil on the strength of better and 71% didn't notice difference, 5,9% thought worst. -
Medical, Legal, Psychosocial, and Ethical Issues of Penile Transplants for Injured Veterans in the United States a Ochasi, N Sopko, G Mamo, V Pepe, a L Burnett, II
The Internet Journal of Law, Healthcare and Ethics ISPUB.COM Volume 11 Number 1 Penile Transplants: To Do or Not To Do: Medical, Legal, Psychosocial, and Ethical Issues of Penile Transplants for Injured Veterans in the United States A Ochasi, N Sopko, G Mamo, V Pepe, A L Burnett, II Citation A Ochasi, N Sopko, G Mamo, V Pepe, A L Burnett, II. Penile Transplants: To Do or Not To Do: Medical, Legal, Psychosocial, and Ethical Issues of Penile Transplants for Injured Veterans in the United States. The Internet Journal of Law, Healthcare and Ethics. 2016 Volume 11 Number 1. DOI: 10.5580/IJLHE.47425 Abstract The genitourinary injuries sustained by soldiers in Iraq and Afghanistan, which make urination, sexual intimacy and fathering a child, more difficult, can cause psychological distress for men, and may even lead to depression. To help ease the burden, Johns Hopkins University has approved a series of 60 experimental penile transplants on wounded veterans with such injuries following the first successful surgery in the US in May of 2016. This article addresses the permissibility of this procedure from the medical, legal, regulatory, sociocultural, religious and ethical perspectives. Medically, since penile transplant fits into the emerging new field of vascularized composite allograft (VCA) there are concerns about the risks for life-long immunosuppression, infection and malignancy. Other concerns include patient’s expectations, donor shortage and lack of public awareness. Legally, the procedure raises issues about the informed consent of donor and recipient, compliance and privacy, as well as need to require a different set of screening procedures and criteria for donation. -
Penile Cancer
Guidelines on Penile Cancer O.W. Hakenberg (chair), E. Compérat, S. Minhas, A. Necchi, C. Protzel, N. Watkin © European Association of Urology 2014 TABLE OF CONTENTS PAGE 1. INTRODUCTION 4 1.1 Publication history 4 1.2 Potential conflict of interest statement 4 2. METHODOLOGY 4 2.1 References 5 3. DEFINITION OF PENILE CANCER 5 4. EPIDEMIOLOGY 5 4.1 References 6 5. RISK FACTORS AND PREVENTION 7 5.1 References 8 6. TNM CLASSIFICATION AND PATHOLOGY 9 6.1 TNM classification 9 6.2 Pathology 10 6.2.1 References 13 7. DIAGNOSIS AND STAGING 15 7.1 Primary lesion 15 7.2 Regional lymph nodes 15 7.2.1 Non-palpable inguinal nodes 15 7.2.2 Palpable inguinal nodes 16 7.3 Distant metastases 16 7.4 Recommendations for the diagnosis and staging of penile cancer 16 7.5 References 16 8. TREATMENT 17 8.1 Treatment of the primary tumour 17 8.1.1 Treatment of superficial non-invasive disease (CIS) 18 8.1.2 Treatment of invasive disease confined to the glans (category Ta/T1a) 18 8.1.2.1 Results of different surgical organ-preserving treatment modalities 18 8.1.2.2 Summary of results of surgical techniques 19 8.1.2.3 Results of radiotherapy for T1 and T2 disease 19 8.1.3 Treatment of invasive disease confined to the corpus spongiosum/glans (Category T2) 20 8.1.4 Treatment of disease invading the corpora cavernosa and/or urethra (category T2/T3) 20 8.1.5 Treatment of locally advanced disease invading adjacent structures (category T3/T4) 20 8.1.6 Local recurrence after organ-conserving surgery 20 8.1.7 Recommendations for stage-dependent local treatment of penile carcinoma.